Healthcare -
Biotechnology - NASDAQ - US
$ 2.405
-2.63 %
$ 366 M
Market Cap
-26.72
P/E
HRTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities HRTX - Heron Therapeutics, Inc.
54.1 M
LAST VALUE
-41.11%
2 YEAR CAGR
-31.46%
5 YEAR CAGR
-1.23%
10 YEAR CAGR